Wayne Kradjan

Dean Emeritus

University of California, San Francisco Medical Center. Pharm.D., 1970 Board Certified Pharmacotherapy Specialist Licensed as a registered pharmacist in California, Oregon and Washington

Profile Field Tabs

Affiliated with: 
College of Pharmacy-Adm
Faculty Type: 
Research/Career Interests: 

Wayne Kradjan joined OSU in January 1999, as Dean of the College of Pharmacy. His academic interests and classroom teaching relate to the pharmacotherapeutic applications of adult general medicine. His research interests, publications and lecturing include the pharmacokinetics and therapeutic effects of bronchodilators and oral hypoglycemic agents, and disease management of heart failure, lipid disorders, peptic ulcer disease, GERD and hepatitis. He was the principal investigator on two grants to assess the effects of community pharmacists' interventions on therapeutic outcomes in patients with asthma and served as a consultant to the Washington State Professional Review Organization Heart Failure Management Program. He is an author of the chapters on Heart Failure and Chronic Obstructive Pulmonary Disease, and section editor for the cardiovascular, pulmonary and gastrointestinal-hepatic sections of the textbook Applied Therapeutics: The Clinical Use of Drugs, and is a co-editor of the companion handbook for the same text. Before assuming his responsibilities at OSU, he was on the faculty at the University of Washington for 28 years, having served at various times as director of the school's post baccalaureate Pharm.D. program, chairman of the Department of Pharmacy and Associate Dean for Professional Programs. He was a visiting faculty to the University of Manchester in England in 1980. He also has extensive experience providing clinical service and teaching on general internal medicine services at an academic health science center and a Veterans Affairs Medical Center.

Selected Publications

Koda-Kimble M, Young L, Kradjan W, Guglielmo J. Applied therapeutics: The Clinical Use of Drugs, 7th Edition. New York:Lippincott, Williams and Wilkins; 2001.

Kradjan W, Schulz R, Christensen D, Stergachis A, Sullivan S, Fullerton DS, Sturm L. Patients' perceived benefit from and satisfaction with asthma related pharmacy services. Journal of the American Pharmacists Association. 1999;39:658-66.

Gibaldi M, Kradjan W. Treating elevated cholesterol levels: the great Satan in perspective. Journal of Clinical Pharmacology.1996;36:189-97.

Kradjan W, Takeuchi K, Opheim K, Wood F. Pharmacokinetics and pharmacodynamics of glipizide after single and divided doses.Pharmacotherapy. 1995;15:465-471.

Kradjan W, Witt D, Opheim K, Wood F. Lack of interaction between glipizide and co-trimoxazole. Journal of Clinical Pharmacology.1994;34:997-1002.

Meyer J, Wenzel C, Kradjan W. Salmeterol: A novel long acting beta agonist. Annals of Pharmacotherapy. 1993;27:1478-87.

DeYoung R, Vetter P, Kradjan W. The pharmacologic treatment of ambulatory chronic obstructive pulmonary disease patients.Journal of Pharmacy Practice. 1992;5:204-16.

Kradjan W, Driesner N, Shoene R, Aubuan T, Emmick G. Effect of age on bronchodilator response. Chest. 1992;101:1545-51.

Kradjan W, Penna P, Dawson K, Andrews A. Experiential training in managed care sites. American Journal of Pharmaceutical Education. 1990;54:285-90.

Kradjan W, Kobayashi K, Bauer L, Horn J, Opheim K, Wood F. Glipizide pharmacokinetics: Effects of age, diabetes, and multiple dosing. Journal of Clinical Pharmacology. 1989;29:1121-27.

Functional Group: